PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Jan-2026 Zura Bio Reports Business Updates and Outlook for 2026 Businesswire
12-Jan-2026 Bio-Sourcing and Zerion Pharma Join Forces to Develop First HER2 Oral Monoclonal Antibody Against Breast Cancer Businesswire
12-Jan-2026 MedaSystems Reports Breakthrough Year of Global Growth, Clinical Trust, and Platform Expansion Businesswire
12-Jan-2026 Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology Businesswire
12-Jan-2026 FairJourney Bio Launches Cryo-EM Services With Advanced Laboratories in San Diego, USA Businesswire
12-Jan-2026 QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth Businesswire
12-Jan-2026 Advicenne Has Successfully Renewed the Marketing Authorization of Sibnayal® in European Union Businesswire
12-Jan-2026 ChemWerth Appoints New General Sales Manager To Increase Its Generic API Footprint in India Businesswire
12-Jan-2026 Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings Businesswire
11-Jan-2026 Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome Businesswire
11-Jan-2026 Debiopharm Deploys Genialis Software to Advance AI-Based Biomarker Discovery Businesswire
10-Jan-2026 Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer Businesswire
10-Jan-2026 MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight Businesswire
09-Jan-2026 Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial Businesswire
09-Jan-2026 Latin America Industrial Cleaning Products Market Report 2025-2034: 6.5% CAGR Projected - ResearchAndMarkets.com Businesswire
09-Jan-2026 Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets Businesswire
09-Jan-2026 Future Trajectory of the $4.7 Billion Protein Expression Market, 2025-2030 - ResearchAndMarkets.com Businesswire
09-Jan-2026 Number of Shares and Voting Rights of ADOCIA as of December 31st, 2025 Businesswire
09-Jan-2026 Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals Businesswire
09-Jan-2026 Diorasis Therapeutics Appoints Richard A. Kresch, MD, to Board of Directors Businesswire